Linda Palczuk insider trades
Open-market stock purchases and sales by Linda Palczuk, Director at Avadel Pharmaceuticals plc, from SEC Form 4 filings since Jul 10, 2017.
Track record: 75% of 8 scored buys are up 5% or more since purchase, averaging +102%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $201K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $465K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $273K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $119K |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $1.7M |
| Feb 12, 2026 | AVDL Avadel Pharmaceuticals plc | Sold (not open market) | $122K |